Sponsors, CROs and academic research teams choosing an eCOA platform for a regulated clinical trial.
Scope Electronic clinical outcome assessment (eCOA) platforms that capture patient-reported (ePRO), clinician-reported, observer-reported and performance outcomes in regulated clinical trials, as a sponsor, CRO or academic research team would shortlist them.
These notes describe the products in the eCOA guide.
Clario
Best for
Global pivotal trials that combine eCOA with cardiac, respiratory, imaging or sensor endpoints
What to consider
Clario has the deepest enterprise eCOA profile here: studies in 120+ countries and 100+ languages, a named eCOA science team and pre-validated assessment libraries. It says it has supported 70% of FDA and EMA new drug approvals since 2015 across its endpoints. Builds are delivered by Clario and prices are not published.
Clinical trials and research studies where ongoing participant engagement is central, with electronic assessments, reminders and follow-up in one study app
What to consider
WeGuide combines electronic outcome assessments with ongoing participant engagement for clinical trials and research studies. Teams connect assessments with consent, reminders and follow-up in a branded study app, with multilingual and wearable-data options. This supports study designs that need participants to stay involved between visits or over time, including investigator-led studies, cohorts and registries. Suitability depends on the assessments and workflows required, rather than study size alone. Confirm instrument licensing, assessment validation and any intensive site-entry or device-logistics needs.
Less suitable for
Protocols requiring a fully managed global provisioned-device fleet or an enterprise EDC and drug-supply suite from the same provider; confirm the required capture modes and services.
Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.
Expand a feature definition or support note for context and its original source.
Clario vs WeGuide (eCOA): category feature evidence and sources. Products are not ranked.
Category feature
Clario
WeGuide
Validated instrument library and licensingFeature definitions
Supported
A library of outcome-assessment instruments is documented.
Extended support
A validated or instrument-author-approved library plus managed instrument licensing are documented.
Clario
Supported
Pre-built, validated assessment libraries, the Rapid Start assessment catalog and an eCOA Science Services team with named scientists.
Validated libraries and science services are documented; managed licensing is not established.
WeGuide
Supported
WeGuide publishes an assessment-instrument library and describes instrument licensing and digital-migration support. Confirm permissions and validation responsibilities for each chosen instrument.
Outcome forms and licensing support are described; confirm author approval and the managed licensing scope for each selected instrument before assuming the extended definition is met.
Regulatory compliance and track recordFeature definitions
Supported
Relevant trial or security controls are stated.
Extended support
Relevant trial controls plus a public ISO/SOC certificate or audit report are documented; a certification claim or logo alone is insufficient.
Clario
Supported
States it has supported 70% of FDA and EMA new drug approvals since 2015 (company-wide, all endpoint types); ISO 27001:2022 and SOC 2 Type II are published separately.
ISO/SOC certifications are stated; this note does not establish a public certificate or audit report.
WeGuide
Supported
WeGuide states ISO 27001:2022 certification and support for GDPR, HIPAA and 21 CFR Part 11. The public material does not provide the certificate or an audit report.
The note reports studies across countries and languages.
WeGuide
Extended support
WeGuide describes BRACE across five countries and INHERIT in ten languages. These are examples of participant outcome collection, rather than a claim of enterprise-scale eCOA deployment.
BYOD and provisioned devices are offered with integrated, pre-validated connected devices.
WeGuide
Supported
Electronic participant outcome forms connect to existing EDC systems through the Integration Engine. Provisioned-device fleet delivery is not established by this source.
Electronic capture and system connections are documented; the source does not establish provisioned-device fleet support.
Time to launch and self-service buildFeature definitions
Supported
A study build process, self-service builder or launch timeframe is documented.
Extended support
Study teams can configure the study themselves, with a stated build or launch timeframe.
Clario
Supported
eCOA Swift deploys early-phase oncology trials in as little as 2 weeks and Rapid Start offers pre-configured assessments; builds are vendor-delivered, no self-service designer published.